Literature DB >> 18449913

Multiple primary malignancies in patients with sporadic pancreatic endocrine tumors.

Volker Fendrich1, Jens Waldmann, Detlef K Bartsch, Katja Schlosser, Matthias Rothmund, Berthold Gerdes.   

Abstract

BACKGROUND: To investigate the appearance of multiple primary malignancies in patients with sporadic neuroendocrine pancreatic tumors (NEPTs).
METHODS: One hundred forty-five patients with NEPTs were treated at the Department of Surgery, Philipps-University Marburg. Multiple primary malignancies included tumors that were not considered to be a metastasis, invasion, or recurrence of NEPTs. Data on sex, age at diagnosis of cancer, follow-up time after diagnosis, and death rate were collected.
RESULTS: Of 115 patients with sporadic NEPTs, 15 (13.0%) patients were identified with at least one malignant tumor, other than a NEPT. The median age at diagnosis of the associated tumor(s) was 57 years (range, 10-72 years). Two of the 15 patients had insulinomas, 5 had gastrinomas and 8 had non-functioning NEPTs, respectively. The risk of developing multiple cancers was the highest for patients with gastrinoma (21.7%), followed by patients with non-functioning NFPTs (20.5%).
CONCLUSIONS: In patients with NEPTs multiple primary malignancies are found more frequently than in the general population. The etiology of the increased risk of other primaries is not clearly defined, but it may be the result of accumulated growth stimulation by the secreted hormones or a genetic alteration that leads to tumorogenesis in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18449913     DOI: 10.1002/jso.21044

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Concomitant endometrial and pancreatic cancers.

Authors:  S Michelle Shiller; Shawna L Bull Phelps; Jeffrey P Lamont; Granger R Scruggs
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

2.  Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation.

Authors:  Martin B Niederle; Bruno Niederle
Journal:  Oncologist       Date:  2011-04-05

Review 3.  Surgical management of pancreatic neuroendocrine tumors.

Authors:  Wataru Kimura; Koji Tezuka; Ichiro Hirai
Journal:  Surg Today       Date:  2011-09-16       Impact factor: 2.549

4.  Secondary malignancy in patients with sporadic neuroendocrine neoplasia.

Authors:  M Krausch; A Raffel; M Anlauf; M Schott; N Lehwald; A Krieg; F Kröpil; K Cupisti; W T Knoefel
Journal:  Endocrine       Date:  2013-03-14       Impact factor: 3.633

5.  Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study.

Authors:  Juan Manuel O'Connor; Fabiana Marmissolle; Claudia Bestani; Veronica Pesce; Susana Belli; Enzo Dominichini; Guillermo Mendez; Paola Price; Nora Giacomi; Alejandro Pairola; Fernando Sánchez Loria; Eduardo Huertas; Claudio Martin; Karina Patane; Claudia Poleri; Moises Rosenberg; Ana Cabanne; Mirta Kujaruk; Analia Caino; Victor Zamora; Javier Mariani; Mariano Dioca; Patricia Parma; Gustavo Podesta; Oscar Andriani; Gabriel Gondolesi; Enrique Roca
Journal:  Mol Clin Oncol       Date:  2014-06-27

6.  Double primary tumors of the pancreas: A case report.

Authors:  Hee Jeong Kim; Mi-Hyun Park; Byungseok Shin
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  A rare case of concomittant pancreatic adenosquamous and neuroendocrine tumours.

Authors:  Izziddine Vial; Ambareen Kausar
Journal:  J Surg Case Rep       Date:  2022-08-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.